Home
About
FAQ
History (23)
Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
Hormone Therapy and Cognitive Aging in Older and Younger Postmenopausal Women: E
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.
Developing and evaluating an automated appendicitis risk stratification algorithm for pediatric patients in the emergency department.
Rosai-Dorfman disease presenting as a suspicious breast mass.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rosai-Dorfman disease presenting as a suspicious breast mass.
Kuzmiak CM, Koomen M, Lininger R, Pisano E. Rosai-Dorfman disease presenting as a suspicious breast mass. AJR Am J Roentgenol. 2003 Jun; 180(6):1740-2.
View in:
PubMed
subject areas
Adult
Breast Neoplasms
Diagnosis, Differential
Female
Histiocytosis, Sinus
Humans
Tomography, X-Ray Computed
authors with profiles
Ruth A. Lininger MD, MPH